BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27253231)

  • 21. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
    Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
    Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography].
    Kusumoto K; Nakai Y; Itokawa Y; Aoki K; Kawamura M; Kikuchi M; Teramura M; Oiwa Y; Kusaka T; Kokuryu H; Yamaoka T; Inatomi O; Katsushima S
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(9):788-795. PubMed ID: 32908109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
    BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
    Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive intravenous hydration with lactated Ringer's solution for prevention of post-ERCP pancreatitis: a prospective randomized multicenter clinical trial.
    Park CH; Paik WH; Park ET; Shim CS; Lee TY; Kang C; Noh MH; Yi SY; Lee JK; Hyun JJ; Lee JK
    Endoscopy; 2018 Apr; 50(4):378-385. PubMed ID: 29237204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.
    Lee TH; Moon JH; Choi HJ; Han SH; Cheon YK; Cho YD; Park SH; Kim SJ
    Gastrointest Endosc; 2012 Sep; 76(3):578-85. PubMed ID: 22771100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nafamostat for Prophylaxis against Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Compared with Gabexate.
    Chang JH; Lee IS; Kim HK; Cho YK; Park JM; Kim SW; Choi MG; Chung IS
    Gut Liver; 2009 Sep; 3(3):205-10. PubMed ID: 20431747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.
    Ueki T; Otani K; Kawamoto K; Shimizu A; Fujimura N; Sakaguchi S; Matsui T
    J Gastroenterol; 2007 Feb; 42(2):161-7. PubMed ID: 17351806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?
    Pezzilli R; Gabbrielli A; Labate AM; D'Alessio P; Barakat B; Costamagna G; Dibenedetti F; Massa M; Merlini G; d'Eril GM
    Hepatogastroenterology; 2003; 50(51):851-5. PubMed ID: 12828103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial.
    Bai Y; Ren X; Zhang XF; Lv NH; Guo XG; Wan XJ; Nie ZG; Han ST; Bie P; Tian DA; Ji M; Li ZS
    Endoscopy; 2015 May; 47(5):415-20. PubMed ID: 25590178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactated Ringer's solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial.
    Mok SRS; Ho HC; Shah P; Patel M; Gaughan JP; Elfant AB
    Gastrointest Endosc; 2017 May; 85(5):1005-1013. PubMed ID: 27816497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
    Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
    Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
    Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
    J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study.
    Yaghoobi M; Pauls Q; Durkalski V; Romagnuolo J; Fogel EL; Tarnasky PR; Aliperti G; Freeman ML; Kozarek RA; Jamidar PA; Wilcox CM; Elta GH; Hawes RH; Wood-Williams A; Cotton PB
    Endoscopy; 2015 Oct; 47(10):884-90. PubMed ID: 26165739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early precut sphincterotomy for difficult biliary access to reduce post-ERCP pancreatitis: a randomized trial.
    Mariani A; Di Leo M; Giardullo N; Giussani A; Marini M; Buffoli F; Cipolletta L; Radaelli F; Ravelli P; Lombardi G; D'Onofrio V; Macchiarelli R; Iiritano E; Le Grazie M; Pantaleo G; Testoni PA
    Endoscopy; 2016 Jun; 48(6):530-5. PubMed ID: 26990509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors of post- endoscopic retrograde cholangiopancreatography pancreatitis in biliary type sphincter of Oddi dysfunction in Japanese patients.
    Miyatani H; Matsumoto S; Mashima H
    J Dig Dis; 2017 Oct; 18(10):591-597. PubMed ID: 28898571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla.
    Xu LH; Qian JB; Gu LG; Qiu JW; Ge ZM; Lu F; Wang YM; Li YM; Lu HS
    J Gastroenterol Hepatol; 2011 Jul; 26(7):1139-44. PubMed ID: 21392105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylaxis of pancreatitis with intravenous ketoprofen in a consecutive population of ERCP patients: a randomized double-blind placebo-controlled trial.
    de Quadros Onófrio F; Lima JCP; Watte G; Lehmen RL; Oba D; Camargo G; Dos Santos CEO
    Surg Endosc; 2017 May; 31(5):2317-2324. PubMed ID: 27651353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.